Coronary Balloon Catheters Market Size, Share & COVID19 Impact Analysis-Global-2023-2029-MedCore-Segmented by: Type (PTCA, Drug-Eluting & Speciality Balloon Catheter)

Coronary Balloon Catheters Market Size, Share & COVID19 Impact Analysis-Global-2023-2029-MedCore-Segmented by: Type (PTCA, Drug-Eluting & Speciality Balloon Catheter)

In 2022, the global market for coronary balloon catheters exceeded a valuation of $963 million. Over the forecast period, it is projected to experience a compound annual growth rate (CAGR) of 2.3%, reaching a value exceeding $1.1 billion.

The comprehensive report suite encompasses the global market for coronary balloon catheters, which includes percutaneous transluminal coronary angioplasty (PTCA) balloons and specialty balloons. Specialty balloons encompass cutting and scoring balloons.

GLOBAL CORONARY BALLOON CATHETER MARKET DATA INCLUDED

Unit Sales, Average Selling Prices, Market Size & Growth Trends
Procedure Volumes
Market Drivers & Limiters
Market Forecasts Until 2029, and Historical Data to 2019
Recent Mergers & Acquisitions
Disease Overviews and Demographic Information
Company Profiles, Product Portfolios, and SWOT for Top Competitors

PROCEDURE VOLUMES

As part of our study on the global coronary balloon catheter market, iData Research has conducted a comprehensive analysis of angiography, angioplasty (or PCI), atherectomy, and catheterization procedure volumes. This analysis has been performed to enhance the accuracy of our market sizing and provide you with detailed information on procedure volumes spanning a 10-year timeframe across 70 countries. By incorporating procedure volume data, we aim to provide a comprehensive understanding of the market dynamics and trends in the coronary balloon catheter industry.

GLOBAL CORONARY BALLOON CATHETER MARKET INSIGHTS

The primary purpose of coronary balloon catheters is to dilate a vessel before the insertion of a stent. The concerns surrounding late stent thrombosis have contributed to an increase in the number of pre-stent dilation procedures, thereby driving market growth. However, the widespread adoption of drug-eluting stents (DESs) has had a limiting impact on the coronary balloon catheter market. DESs have demonstrated effectiveness in reducing restenosis rates and minimizing the need for pre-stent dilation procedures. While coronary balloon catheters may still be used after DES procedures, the overall reduction in restenosis has resulted in a decrease in unit sales for both percutaneous transluminal coronary angioplasty (PTCA) and specialty balloon catheters.

GLOBAL CORONARY BALLOON CATHETER MARKET SHARE INSIGHTS

Boston Scientific holds the top position in the global coronary balloon catheter market, with a strong presence in the percutaneous transluminal coronary angioplasty (PTCA) balloon segment, where it commands a majority share.

Philips entered the market by acquiring Spectranetics, establishing its position primarily in the specialty balloon catheter segment, where it has secured a significant market share.

Medtronic, like other major competitors in the global coronary balloon catheter market, offers a wide range of devices in both the coronary and peripheral markets. This allows the company to strategically bundle products and leverage its position in the competitive landscape.

WHY CHOOSE IDATA?

Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.

Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.

Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.

Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.

This MedCore is also found in the full report suite titled Global Market Report for Interventional Cardiology Devices – MedSuite